Dupuis J - Search Results

1

Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.

Ranchoux B, Nadeau V, Bourgeois A, Provencher S, Tremblay É, Omura J, Coté N, Abu-Alhayja'a R, Dumais V, Nachbar RT, Tastet L, Dahou A, Breuils-Bonnet S, Marette A, Pibarot P, Dupuis J, Paulin R, Boucherat O, Archer SL, Bonnet S, Potus F. Ranchoux B, et al. Among authors: dupuis j. Circ Res. 2019 Aug 2;125(4):449-466. doi: 10.1161/CIRCRESAHA.118.314555. Epub 2019 Jun 3. Circ Res. 2019. PMID: 31154939

2

EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension.

Prié S, Stewart DJ, Dupuis J. Prié S, et al. Among authors: dupuis j. Circulation. 1998 Jun 2;97(21):2169-74. doi: 10.1161/01.cir.97.21.2169. Circulation. 1998. PMID: 9626178

3

Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction.

Dupuis J, Rouleau JL, Cernacek P. Dupuis J, et al. Circulation. 1998 Oct 20;98(16):1684-7. doi: 10.1161/01.cir.98.16.1684. Circulation. 1998. PMID: 9778335

4

Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension.

Jasmin JF, Lucas M, Cernacek P, Dupuis J. Jasmin JF, et al. Among authors: dupuis j. Circulation. 2001 Jan 16;103(2):314-8. doi: 10.1161/01.cir.103.2.314. Circulation. 2001. PMID: 11208695

5

Cellular and molecular basis of pulmonary arterial hypertension.

Morrell NW, Adnot S, Archer SL, Dupuis J, Lloyd Jones P, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX, Weir EK. Morrell NW, et al. Among authors: dupuis j. J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S20-S31. doi: 10.1016/j.jacc.2009.04.018. J Am Coll Cardiol. 2009. PMID: 19555855 Free PMC article. Review.

6

Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases.

Dupuis J, Guazzi M. Dupuis J, et al. Can J Cardiol. 2015 Apr;31(4):416-29. doi: 10.1016/j.cjca.2014.10.012. Epub 2014 Oct 14. Can J Cardiol. 2015. PMID: 25840093 Review.

7

Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).

Dayeh NR, Ledoux J, Dupuis J. Dayeh NR, et al. Among authors: dupuis j. Prog Cardiovasc Dis. 2016 Jul-Aug;59(1):11-21. doi: 10.1016/j.pcad.2016.05.002. Epub 2016 May 16. Prog Cardiovasc Dis. 2016. PMID: 27195752 Free article. Review.

8

PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.

Nguyen QT, Nsaibia MJ, Sirois MG, Calderone A, Tardif JC, Fen Shi Y, Ruiz M, Daneault C, Gagnon L, Grouix B, Laurin P, Dupuis J. Nguyen QT, et al. Among authors: dupuis j. Cardiovasc Res. 2020 Jan 1;116(1):171-182. doi: 10.1093/cvr/cvz034. Cardiovasc Res. 2020. PMID: 30753422

9

Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension.

Zhu L, Liu F, Hao Q, Feng T, Chen Z, Luo S, Xiao R, Sun M, Zhang T, Fan X, Zeng X, He J, Yuan P, Liu J, Ruiz M, Dupuis J, Hu Q. Zhu L, et al. Among authors: dupuis j. Circulation. 2021 May 4;143(18):1775-1792. doi: 10.1161/CIRCULATIONAHA.120.046542. Epub 2021 Mar 4. Circulation. 2021. PMID: 33660517

10

Human pulmonary circulation is an important site for both clearance and production of endothelin-1.

Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Dupuis J, et al. Circulation. 1996 Oct 1;94(7):1578-84. doi: 10.1161/01.cir.94.7.1578. Circulation. 1996. PMID: 8840847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

990 results

Search Page